{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:26:26Z","timestamp":1783117586339,"version":"3.54.6"},"reference-count":13,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Public Health Challenges"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The COVID\u201019 vaccination program is the most extensive vaccination program held in Nigeria to date. As of September 21, 2022, more than 31 million people have been fully vaccinated which made up 15% of the entire population. Following the global COVID\u201019 vaccination goal, Nigeria was expected to vaccinate 40% of its population in 2021 and reach the 70% vaccination threshold before the end of 2022. Currently, Nigeria is nowhere near the global vaccination goal due to various challenges encountered by the program. Challenges such as distrust in government, poor cold\u2010chain management, and poor communication during the onset of the program all contributed to the inability to attain the set goal. With the pledge of Global Alliance for Vaccines and Immunizations to extend the malaria vaccination program to other Sub\u2010Saharan African countries after the success of the first dose vaccination in Ghana, Kenya, and Malawi and the recent reemergence of monkeypox virus in Africa which also requires vaccination to curtail its spread, it is important that Nigeria, in preparation for these vaccination programs, learn from some of the challenges that the COVID\u201019 vaccination program encountered and take actions to ensure greater success in future vaccination programs in the country. This paper aims to give an overview of the COVID\u201019 vaccination program in Nigeria, highlight the challenges encountered, and provide recommendations for better future vaccination initiatives in the country.<\/jats:p>","DOI":"10.1002\/puh2.57","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T07:40:16Z","timestamp":1673595616000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["COVID\u201019 vaccination in Nigeria: Challenges and recommendations for future vaccination initiatives"],"prefix":"10.1002","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0391-3636","authenticated-orcid":false,"given":"Taiwo Oluwaseun","family":"Sokunbi","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy Obafemi Awolowo University  Ile\u2010Ife Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-5782","authenticated-orcid":false,"given":"Abdmateen Temitope","family":"Oluyedun","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Obafemi Awolowo University  Ile\u2010Ife Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Ayomide","family":"Adegboye","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Obafemi Awolowo University  Ile\u2010Ife Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glory Peace","family":"Oluwatomisin","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy Obafemi Awolowo University  Ile\u2010Ife Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmumin Damilola","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences University of Ilorin  Ilorin Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2021.38.230.27325"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104506"},{"key":"e_1_2_9_4_1","unstructured":"World Health Organization.Strategy to Achieve Global COVID\u201019 Vaccination by Mid\u20102022. Page 4. Accessed 22 September 2022. Available from:https:\/\/cdn.who.int\/media\/docs\/default\u2010source\/immunization\/covid\u201019\/strategy\u2010to\u2010achieve\u2010global\u2010covid\u201019\u2010vaccination\u2010by\u2010mid\u20102022.pdf?sfvrsn=5a68433c_5"},{"key":"e_1_2_9_5_1","unstructured":"Our World in Data.Coronavirus (COVID\u201019) Vaccinations.2022. Accessed 21 September 2022. Available from:https:\/\/ourworldindata.org\/covid\u2010vaccinations?country=NGA"},{"key":"e_1_2_9_6_1","unstructured":"Unicef.COVID\u201019 Vaccines Shipped by COVAX Arrive in Nigeria.2021. March 2 2021. Accessed 22 September 2022. Available from:https:\/\/www.unicef.org\/wca\/press\u2010releases\/covid\u201019\u2010vaccines\u2010shipped\u2010covax\u2010arrive\u2010nigeria"},{"key":"e_1_2_9_7_1","unstructured":"COVID\u201019 Vaccine Tracker.Nigeria. Accessed 5 October 2022. Available from:https:\/\/covid19.trackvaccines.org\/country\/nigeria\/"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0267691"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264371"},{"key":"e_1_2_9_10_1","unstructured":"Gisf.COVID\u201019 Vaccination in Nigeria: What are the Implications for International NGOs?2020. Accessed 23 September 2022. Available from:https:\/\/gisf.ngo\/blogs\/covid\u201019\u2010vaccinations\u2010in\u2010nigeria\u2010what\u2010are\u2010the\u2010implications\u2010for\u2010international\u2010ngos\/"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.29392\/001c.21404"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071008"},{"key":"e_1_2_9_13_1","unstructured":"World Health Organization.Over 1 Million African Children Protected by First Vaccine. April 21 2022. Accessed on 25 September 2022. Available from:https:\/\/www.who.int\/news\/item\/21\u201004\u20102022\u2010over\u20101\u2010million\u2010african\u2010children\u2010protected\u2010by\u2010first\u2010malaria\u2010vaccine"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1328"}],"container-title":["Public Health Challenges"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/puh2.57","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/puh2.57","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/puh2.57","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:54:31Z","timestamp":1692626071000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/puh2.57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1002\/puh2.57"],"URL":"https:\/\/doi.org\/10.1002\/puh2.57","archive":["Portico"],"relation":{},"ISSN":["2769-2450","2769-2450"],"issn-type":[{"value":"2769-2450","type":"print"},{"value":"2769-2450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]},"assertion":[{"value":"2022-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e57"}}